Drug Profile
Research programme: heat stable hepatitis B vaccine - C-Pharma
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator C-Pharma
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Hepatitis-B in Canada (Parenteral)
- 26 Apr 2011 Early research in Hepatitis B in Canada (Parenteral)